Medicine Description rivaflowva 20 mg
rivaflowva 20 tablets 20 mg is a medication that contains rivaroxaban, a direct factor Xa inhibitor. By binding to factor Xa, rivaroxaban effectively prevents the conversion of prothrombin to thrombin, a crucial step in the coagulation cascade. This inhibition leads to a decrease in thrombin generation, thereby reducing the formation of fibrin clots. Unlike traditional anticoagulants that are vitamin K-dependent, rivaroxaban provides a more predictable anticoagulant effect without the need for routine monitoring, making it a versatile choice in managing thromboembolic conditions.
Indications and Uses of rivaflowva 20 tablets 20 mg
- Prevention of venous thromboembolism (VTE) in patients undergoing elective hip or knee replacement surgery.
- Reduction in the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation.
- Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE).
- Prevention of recurrent DVT and PE following initial treatment.
Side Effects of rivaflowva 20 tablets 20 mg
- Bleeding complications, including serious or fatal bleeding.
- Gastrointestinal disturbances such as nausea and diarrhea.
- Elevated liver enzymes.
- Skin reactions including rash and itching.
Storage and Handling
Store at room temperature, away from light and moisture. Keep out of reach of children. Do not use after the expiration date printed on the package.
Patient Advice and Precautions
Patients should be instructed to report any signs of unusual bleeding or bruising. It's important to inform healthcare providers about any ongoing medications or supplements, particularly those that can increase bleeding risk. Regular follow-ups may be necessary to monitor renal function and liver health.